Breaking News Instant updates and real-time market news.

OSPN

OneSpan

$14.10

0.05 (0.36%)

07:28
05/31/19
05/31
07:28
05/31/19
07:28

OneSpan initiated with a Neutral at Wedbush

Wedbush analyst Daniel Ives initiated OneSpan with a Neutral rating and $17 price target, saying the company has done a "commendable" job transitioning its business to a modern software security player that offers extensive authentication and fraud prevention solutions with a total addressable market that is now over $20B. OneSpan's Trusted Identity strategy and platform provides a unique value proposition as an open, cloud based platform that enables institutions to on-board customers, authenticate transactions, manage fraud, comply with regulations, and secure open-banking in a safe and frictionless method, Ives tells investors in a research note.

  • 03

    Jun

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

OSPN OneSpan
$14.10

0.05 (0.36%)

02/20/19
IMPC
02/20/19
DOWNGRADE
Target $20
IMPC
In-Line
Imperial downgrades OneSpan to In-Line amid 15% post-earnings rally
Imperial Capital analyst Saliq Khan downgraded OneSpan to In-Line from Outperform while raising his price target for the shares to $20 from $19 following the company's Q4 results. The stock in midday trading is up 15%, or $2.49, to $19.26. The analyst says that while he remains positive on OneSpan, his new price target leaves little upside from current share levels. Further, given the transactional nature the company's business, Khan expects its "revenues to be lumpy." However, the analyst is encouraged by the reoccurring revenue aspect of the business model.
02/20/19
IMPC
02/20/19
DOWNGRADE
IMPC
In-Line
OneSpan downgraded to In-Line from Outperform at Imperial Capital
01/03/19
NATL
01/03/19
INITIATION
Target $20
NATL
Buy
OneSpan initiated with a Buy at National Securities
National Securities analyst Matthew Galinko initaited OneSpan with a Buy and $20 price target saying he expects operating leverage to re-emerge beginning in 2019 following the company's revenue shift mix from hardware authenticators to software security and eSignature products. Galinko expects a scaled up software business to drive higher margins over time and support multiple expansion.
12/03/18
SIDC
12/03/18
INITIATION
Target $23
SIDC
Buy
OneSpan re-initiated with a Buy at Sidoti
Sidoti re-initiated coverage of OneSpan with a Buy rating and $23 price target.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$63.57

-0.04 (-0.06%)

08:29
06/24/19
06/24
08:29
06/24/19
08:29
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$1.09

-0.005 (-0.46%)

08:29
06/24/19
06/24
08:29
06/24/19
08:29
Hot Stocks
NantKwest launches Phase 1 PD-L1 t-haNK trial »

NantKwest announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$119.58

-0.86 (-0.71%)

08:29
06/24/19
06/24
08:29
06/24/19
08:29
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.68

-0.51 (-0.88%)

08:29
06/24/19
06/24
08:29
06/24/19
08:29
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$60.99

-0.21 (-0.34%)

08:28
06/24/19
06/24
08:28
06/24/19
08:28
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:28
06/24/19
06/24
08:28
06/24/19
08:28
Conference/Events
Citigroup to hold a conference »

ASEAN C-Suite Investor…

XLP

Consumer Staples Sector SPDR

$58.68

-0.66 (-1.11%)

08:28
06/24/19
06/24
08:28
06/24/19
08:28
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$93.72

0.04 (0.04%)

08:28
06/24/19
06/24
08:28
06/24/19
08:28
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNLN

Greenlane

$10.22

-1.03 (-9.16%)

08:28
06/24/19
06/24
08:28
06/24/19
08:28
Hot Stocks
Greenlane does not expect 'material impact' from San Francisco e-cigarette ban »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$153.91

-1.38 (-0.89%)

08:27
06/24/19
06/24
08:27
06/24/19
08:27
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDD

3D Systems

$8.96

0.5 (5.91%)

, ABT

Abbott

$85.04

0.07 (0.08%)

08:27
06/24/19
06/24
08:27
06/24/19
08:27
Conference/Events
American Society of Echocardiography (ASE) to hold scientific sessions »

ASE 2019 Scientific…

DDD

3D Systems

$8.96

0.5 (5.91%)

ABT

Abbott

$85.04

0.07 (0.08%)

CAE

CAE

$26.50

-0.145 (-0.54%)

LNTH

Lantheus

$27.85

-0.23 (-0.82%)

PFE

Pfizer

$43.68

0.07 (0.16%)

PHG

Philips

$43.10

-0.15 (-0.35%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ALIOF

Actelion

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 30

    Jul

  • 28

    Aug

  • 16

    Sep

DIA

Diamonds Fund ETF

$267.01

-1.01 (-0.38%)

08:27
06/24/19
06/24
08:27
06/24/19
08:27
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$293.99

-1.95 (-0.66%)

08:27
06/24/19
06/24
08:27
06/24/19
08:27
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNLN

Greenlane

$10.22

-1.03 (-9.16%)

08:27
06/24/19
06/24
08:27
06/24/19
08:27
Hot Stocks
Greenlane says does not 'support complete ban' of e-cigarettes »

Greenlane Holdings issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$85.04

0.07 (0.08%)

, ABMD

Abiomed

$255.76

-4.57 (-1.76%)

08:26
06/24/19
06/24
08:26
06/24/19
08:26
Conference/Events
Academy for Continued Healthcare Learning to hold a summit »

Advanced Endovascular…

ABT

Abbott

$85.04

0.07 (0.08%)

ABMD

Abiomed

$255.76

-4.57 (-1.76%)

BSX

Boston Scientific

$41.69

-0.17 (-0.41%)

PHG

Philips

$43.10

-0.15 (-0.35%)

AZN

AstraZeneca

$41.35

-0.26 (-0.62%)

MDT

Medtronic

$99.39

0.13 (0.13%)

CSII

Cardiovascular Systems

$42.93

-0.5 (-1.15%)

PTLA

Portola Pharmaceuticals

$27.38

0.24 (0.88%)

REGN

Regeneron

$320.11

-0.47 (-0.15%)

TRUMY

Terumo

$0.00

(0.00%)

TFX

Teleflex

$334.59

-0.61 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 17

    Jul

  • 25

    Sep

  • 13

    Nov

SR

Spire

$85.46

0.13 (0.15%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Conference/Events
Spire management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

XLF

Financial Select Sector

$27.21

-0.22 (-0.80%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$5.48

-0.11 (-1.97%)

, CAH

Cardinal Health

$44.70

-0.09 (-0.20%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Conference/Events
Drug Information Association to hold a meeting »

2019 Global Annual…

ADMS

Adamas Pharmaceuticals

$5.48

-0.11 (-1.97%)

CAH

Cardinal Health

$44.70

-0.09 (-0.20%)

CRM

Salesforce

$156.89

-0.39 (-0.25%)

DTRK

DATATRAK International

$0.00

(0.00%)

ESRX

Express Scripts

$0.00

(0.00%)

HURN

Huron

$51.85

-0.01 (-0.02%)

INSM

Insmed

$26.76

0.31 (1.17%)

IQV

Iqvia

$158.62

4.07 (2.63%)

JAZZ

Jazz Pharmaceuticals

$134.37

-1 (-0.74%)

LIOX

Lionbridge

$0.00

(0.00%)

MASI

Masimo

$144.30

-2.89 (-1.96%)

MEDP

Medpace

$62.62

1.2897 (2.10%)

MSFT

Microsoft

$136.94

0.09 (0.07%)

PRAH

PRA Health

$99.07

0.17 (0.17%)

SENS

Senseonics

$2.01

-0.015 (-0.74%)

VEEV

Veeva

$168.73

-2.505 (-1.46%)

WX

WuXi PharmaTech

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

  • 12

    Sep

RTN

Raytheon

$182.79

0.52 (0.29%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Downgrade
Raytheon rating change  »

Raytheon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NERV

Minerva

$4.23

0.03 (0.71%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Conference/Events
Minerva to hold a conference call »

Chairman & CEO, Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

NEWT

Newtek Business Services

$22.87

(0.00%)

08:25
06/24/19
06/24
08:25
06/24/19
08:25
Conference/Events
Newtek Business Services to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

SMTC

Semtech

$46.32

-0.2 (-0.43%)

08:24
06/24/19
06/24
08:24
06/24/19
08:24
Conference/Events
Semtech management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 11

    Jul

  • 18

    Jul

APEN

Apollo Endosurgery

$3.84

(0.00%)

08:24
06/24/19
06/24
08:24
06/24/19
08:24
Hot Stocks
Apollo Endosurgery completes patient enrollment for MERIT trial »

Apollo Endosurgery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGNX

Progenics

$5.21

0.22 (4.41%)

08:23
06/24/19
06/24
08:23
06/24/19
08:23
Hot Stocks
Progenics files investor presentation rebutting Velan's claims »

Progenics Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$107.10

-0.66 (-0.61%)

08:23
06/24/19
06/24
08:23
06/24/19
08:23
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.